71 episodes

For healthcare providers especially pharmacists, nurses and physicians, we work to provide current information on drug updates, changes in the marketplace, and hot topics in the pharmacy industry.

The Rx Daily Dose Ian Parnigoni PharmD.

    • Health & Fitness
    • 5.0 • 14 Ratings

For healthcare providers especially pharmacists, nurses and physicians, we work to provide current information on drug updates, changes in the marketplace, and hot topics in the pharmacy industry.

    Episode 71 - Cyltezo, Seglentis, & COVID EUA

    Episode 71 - Cyltezo, Seglentis, & COVID EUA

    In today’s episode we have updates which include approval of Cyltezo, an interchangeable biosimilar to Humira and approval of Seglentis for acute pain management. We’ll also be going over approval of an EUA for the Pfizer COVID19 vaccine for 5 through 11 year old age range. Don't forget to like, share and subscribe, and ENJOY!

    • 15 min
    Episode 70 - Opzelura, Qulipta, & Livmarli

    Episode 70 - Opzelura, Qulipta, & Livmarli

    In today’s episode we have updates which include approval of Opzelura a new topical treatment for atopic dermatitis, and approval of Qulipta for migraine prevention. We'll also be going over approval of Livmarli for symptoms in patients with Alagille syndrome - also known as ALGS). Don't forget to like, share and subscribe, and ENJOY!

    • 8 min
    Episode 69 - Exkivity, Tivdak, & COVID updates

    Episode 69 - Exkivity, Tivdak, & COVID updates

    In today’s episode we have updates which include approval of Exkivity, a new treatment for non small cell lung cancer, approval of Tivdak for cervical cancer, and approval of Byooviz a new biosimilar for Lucentis. We'll also be going over the new recommendation for Pfizer Covid vaccine booster shots. Don't forget to like, share and subscribe, and ENJOY!

    • 15 min
    Episode 68 - Skytrofa, Invega, & JAK warning

    Episode 68 - Skytrofa, Invega, & JAK warning

    In today’s episode we have updates which include approval of Skytrofa, a new human growth hormone, and approval of Invega Hafyera, a twice yearly treatment for schizophrenia. We'll also be going over a new warning issued by the FDA on JAK inhibitors. Don't forget to like, share and subscribe, and ENJOY!

    • 11 min
    Episode 67 - Comirnaty, COVID EUA, & Welireg

    Episode 67 - Comirnaty, COVID EUA, & Welireg

    In today’s episode we have a few updates to discuss with everyone, and first probably the big news everyone heard about is the official approval of the BioNTech COVID vaccine just this past week. We’ll also talk through a new EUA for COVID vaccines in certain individual and approval of Welireg for adults with von Hippel-Lindau disease. Don't forget to like, share and subscribe, and ENJOY!

    • 14 min
    Episode 66 - Semglee, Nexviazyme, & Rezurock

    Episode 66 - Semglee, Nexviazyme, & Rezurock

    In today’s episode we have a few updates to talk through - the first is approval of a new Lantus biosimilar called Semglee that will be the first interchangeable insulin product. We'll also talk through approval of Nexviazyme for Pompe disease and approval of Rezurock for chronic graft vs host disease. Don't forget to like, share and subscribe, and ENJOY!

    • 12 min

Customer Reviews

5.0 out of 5
14 Ratings

14 Ratings

Gibbs1974 ,

Excellent Information

These Podcasts are invaluable. I love how you cut to the chase both on the clinical data and the economic impact. Keep up the great work!!!

Top Podcasts In Health & Fitness

You Might Also Like